PAMELA CRISCITIELLO: Open Payments
NPI 1790479152 · BRYAN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,650 in 58 payments from 21 companies in 2025. Trend: 2023 $1,058 · 2024 $2,802 · 2025 $2,650
Food & beverage: $1,458Long term medical supply or device loan: $1,000Education: $193
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 21 | $1,134 |
| ABBVIE INC. | 3 | $252 |
| Janssen Biotech, Inc. | 5 | $222 |
| Lilly USA, LLC | 3 | $218 |
| Regeneron Healthcare Solutions, Inc. | 4 | $187 |
| JAZZ PHARMACEUTICALS INC. | 2 | $134 |
| SEAGEN INC. | 1 | $95 |
| PFIZER INC. | 3 | $50 |
| Celgene Corporation | 2 | $49 |
| Incyte Corporation | 2 | $39 |
Products named: KISQALI, TECVAYLI, VRAYLAR, LYNOZYFIC, ELAHERE, XYWAV, LIBTAYO, PADCEV.
Industry payments across TX — which companies pay providers there.
